Cargando…
Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials
Patients with cirrhosis who develop tense ascites and hepatorenal syndrome have a very high mortality and present a management challenge. Current debate stems from a lack of studies evaluating changes in effective arterial blood volume following paracentesis or targeting fluid replacement with appro...
Autores principales: | Mookerjee, Rajeshwar P, Jalan, Rajiv |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2447551/ https://www.ncbi.nlm.nih.gov/pubmed/18394181 http://dx.doi.org/10.1186/cc6804 |
Ejemplares similares
-
Inotropes in goal-directed therapy: Do we need 'goals'?
por: Futier, Emmanuel, et al.
Publicado: (2010) -
Acute stroke: we have the treatments and we have the evidence – we need to use them
por: Quinn, Terence J, et al.
Publicado: (2007) -
Goal-directed or goal-misdirected - how should we interpret the literature?
por: Roche, Anthony M, et al.
Publicado: (2010) -
Goal directed therapy: how long can we wait?
por: Gordon, Anthony C, et al.
Publicado: (2005) -
Early goal-directed therapy: what do we do now?
por: Levy, Mitchell M
Publicado: (2014)